Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01626144 · ClinicalTrials.gov registry record
Metabolizing Enzyme Genotype Versus Exemestane Metabolism Profiles
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 170
- Enrollment target
NCT01626144: Completed study, sponsored by Milton S. Hershey Medical Center.
NCT01626144 is a clinical trial that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 170 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01626144 has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 170 participants
- Enrollment target
Study Summary
It is the investigators hypothesis that exemestane (EXE) metabolism is an important source of the inter-individual variation in EXE metabolic profiles and that polymorphisms in EXE-metabolizing enzymes may potentially play a role in affecting EXE therapeutic efficacy and toxicity. The goals of this clinical study are to (1) establish EXE metabolism profile kinetics, and (2) determine whether correlations exist in vivo between metabolizing enzyme genotype and urinary EXE metabolite profiles in women being treated with EXE. Together, these studies will allow us to fully characterize functionally-relevant polymorphisms in the EXE-metabolizing enzyme pathway that are potentially important in EXE clinical efficacy.
Primary Outcome
Functional genotypes will be determined for EXE-metabolizing enzymes and will be correlated with blood/urinary EXE metabolism profiles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2011-09 |
| Est. Completion | 2018-05-01 |
What the finished NCT01626144 record still lists
NCT01626144 is an observational study that tracks outcomes without assigning an intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01626144 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01626144 about?
NCT01626144 is a clinical study titled "Metabolizing Enzyme Genotype Versus Exemestane Metabolism Profiles". It is the investigators hypothesis that exemestane (EXE) metabolism is an important source of the inter-individual variation in EXE metabolic profiles and that polymorphisms in EXE-metabolizing enzymes may potentially play a role in affecting EXE therapeutic efficacy and toxicity. The goals of this ...
What is the current status of trial NCT01626144?
This trial is currently completed. The enrollment target is 170 participants. The study started on 2011-09. Estimated completion is 2018-05-01.
Who is sponsoring clinical trial NCT01626144?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia